FLORHAM PARK, N.J., March 07, 2023 (WORLD WIRE SERVICE)– PDS Biotechnology Firm PDSB, a clinical-stage immunotherapy firm creating an expanding pipe of targeted immunotherapies for cancer cells and also contagious illness, today revealed that Dr. Frank Bedu-Addo, Head Of State and also Ceo, will certainly provide at the 33rd Yearly Oppenheimer Health care Seminar being held practically on March 13-15, 2023.
Oppenheimer Seminar
Discussion Day: Tuesday, March 14, 2023
Time: 8:00 AM ET
Capitalists can sign up for the webcast here
Complying with the meeting, a webcast replay of the discussion will certainly be offered on the Capitalist area of the firm’s web site, PDS Biotechnology.
Concerning PDS Biotechnology
PDS Biotech is a clinical-stage immunotherapy firm creating an expanding pipe of targeted cancer cells and also contagious illness immunotherapies based upon our exclusive Versamune ®, PDS0301, and also Infectimune ™ T cell-activating systems. Our company believe our targeted Versamune ®(* )and also PDS0301 based prospects have the prospective to get over the restrictions of present immunotherapy methods via the activation of the best kind, amount and also strength of T cells. To day, our lead Versamune ® professional prospect, PDS0101, has actually shown the capacity to decrease lumps and also maintain illness in mix with authorized and also investigational therapies in individuals with a wide variety of HPV16-associated cancers cells in several Stage 2 professional tests. Our Infectimune ™ based injections have actually additionally shown the prospective to generate not just durable and also sturdy reducing the effects of antibody feedbacks, however additionally effective T cell feedbacks, consisting of resilient memory T cell feedbacks in pre-clinical research studies to day. To get more information, please see or follow us on Twitter at @PDSBiotech.www.pdsbiotech.com Capitalist Get In Touches With:
Deanne Randolph
PDS Biotech
Phone: +1 (908) 517-3613
Email: [email protected]
Abundant Cockrell
CG Funding
Phone: +1 (404) 736-3838
Email: [email protected]
Media Contacts:
Dave Schemelia
Tiberend Strategic Advisors, Inc.
Phone: +1 (609) 468-9325
[email protected]
Expense Borden
Phone: +1 (732) 910-1620
[email protected]
